General Information of Drug (ID: DM9FHV8)

Drug Name
CK-2127107 Drug Info
Indication
Disease Entry ICD 11 Status REF
Amyotrophic lateral sclerosis 8B60.0 Phase 2 [1]
Spinal muscular atrophy 8B61 Phase 2 [1]
Muscle atrophy FB32.Y Phase 1 [2]
Cross-matching ID
PubChem CID
67454400
CAS Number
CAS 1345410-31-2
TTD Drug ID
DM9FHV8

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
CK-2017357 DMJ9ZIY Amyotrophic lateral sclerosis 8B60.0 Phase 3 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Fast skeletal muscle troponin complex (TNNC2) TTYUMF5 TNNC2_HUMAN Modulator [3]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800037810)
3 Activation of fast skeletal muscle troponin as a potential therapeutic approach for treating neuromuscular diseases. Nat Med. 2012 Feb 19;18(3):452-5.